NADINE M SHABEEB

Allopathic & Osteopathic Physicians|Dermatology MADISON, WI NPI 1669903076

General Payments — all program years on this page

$1,226.53

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 31
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $415.09 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $316.0920
Education $99.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $259.853
2019 $391.655
2020 $69.991
2021 $89.951
2024 $415.0921

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078837770 Janssen Biotech, Inc. $7.69 06/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078837796 Janssen Biotech, Inc. $6.35 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078837810 Janssen Biotech, Inc. $7.20 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078837832 Janssen Biotech, Inc. $2.99 11/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078837834 Janssen Biotech, Inc. $5.91 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078837864 Janssen Biotech, Inc. $6.70 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078837888 Janssen Biotech, Inc. $99.00 03/25/2024 Education Undisputed 01/23/2026 View at CMS
1087326337 Novartis Pharmaceuticals Corporation $18.67 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101249179 E.R. Squibb & Sons, L.L.C. $21.43 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106060608 ABBVIE INC. $14.11 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106060610 ABBVIE INC. $22.42 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106060612 ABBVIE INC. $24.21 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106060614 ABBVIE INC. $16.85 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106060616 ABBVIE INC. $17.55 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118104809 Boehringer Ingelheim Pharmaceuticals, Inc. $30.90 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127931592 Dermavant Sciences, Inc. $23.25 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127931596 Dermavant Sciences, Inc. $14.95 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127931600 Dermavant Sciences, Inc. $19.81 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127931603 Dermavant Sciences, Inc. $19.98 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145327362 Galderma Laboratories, L.P. $15.21 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152185919 SUN PHARMACEUTICAL INDUSTRIES INC. $19.91 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.